Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform
Why now
Thesis: Small-cap medtech collaboration, no disclosed financials
Catalyst to watch: Commercial launch or order announcements
Main risk: No revenue terms disclosed; integration may stall
Why it matters
Partnership expands imaging capability for Accuray's CyberKnife platform, but financial terms and revenue impact are undisclosed.
Details
MADISON, Wis., Sept. 27, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced that it had entered into agreements with Samsung HME America, Inc., dba NeuroLogica Corp. ("Samsung NeuroLogica") to pursue advanced volumetric imaging capabilities for the CyberKnife® System....
Related assets & topics
HealthcareSources
- prnewswire · 2026-09-27 15:15 UTC